Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred I Neugut

Showing results (161-170 of 592) with videos related to

Pageof 60
Sort By:
Breast Cancer (Tokyo, Japan)|May 18, 2021
PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based studyLin Wang, Qian Li, Vasily N Aushev, et al.
Journal of Neuro-Oncology|November 16, 2017
The modified frailty index and 30-day adverse events in oncologic neurosurgeryBrett E Youngerman, Alfred I Neugut, Jingyan Yang, et al.
Journal of Insurance Medicine (New York, N.Y.)|March 26, 2009
Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United StatesPeter H R Green, Alfred I Neugut, Afzal J Naiyer, et al.
Cancer Investigation|September 21, 2007
Cancer incidence and mortality in the CaribbeanAdrienne A Phillips, Judith S Jacobson, Carol Magai, et al.
Cancer|April 22, 2005
Hormone receptor status and survival in a population-based cohort of patients with breast carcinomaVictor R Grann, Andrea B Troxel, Naseem J Zojwalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Contraindicated use of bevacizumab and toxicity in elderly patients with cancerDawn L Hershman, Jason D Wright, Emerson Lim, et al.
International Journal of Hygiene and Environmental Health|July 29, 2019
Self-reported residential pesticide use and survival after breast cancerNicole M Niehoff, Marilie D Gammon, Humberto Parada, et al.
JCO Global Oncology|December 22, 2021
Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public HospitalsYoanna Pumpalova, Alexandra M Rogers, Sarah Xinhui Tan, et al.
Cancer Investigation|January 16, 2010
Treatment interruption and discontinuation in radiotherapy for rectal cancerBenjamin Lebwohl, Leslie Ballas, Yin Cao, et al.
Cancer|June 7, 2005
Barriers to minority participation in breast carcinoma prevention trialsVictor R Grann, Judith S Jacobson, Andrea B Troxel, et al.
Pageof 60

Showing results (161-170 of 592) with videos related to

Sort By:
Pageof 60
Breast Cancer (Tokyo, Japan)|May 18, 2021
PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based studyLin Wang, Qian Li, Vasily N Aushev, et al.
Journal of Neuro-Oncology|November 16, 2017
The modified frailty index and 30-day adverse events in oncologic neurosurgeryBrett E Youngerman, Alfred I Neugut, Jingyan Yang, et al.
Journal of Insurance Medicine (New York, N.Y.)|March 26, 2009
Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United StatesPeter H R Green, Alfred I Neugut, Afzal J Naiyer, et al.
Cancer Investigation|September 21, 2007
Cancer incidence and mortality in the CaribbeanAdrienne A Phillips, Judith S Jacobson, Carol Magai, et al.
Cancer|April 22, 2005
Hormone receptor status and survival in a population-based cohort of patients with breast carcinomaVictor R Grann, Andrea B Troxel, Naseem J Zojwalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Contraindicated use of bevacizumab and toxicity in elderly patients with cancerDawn L Hershman, Jason D Wright, Emerson Lim, et al.
International Journal of Hygiene and Environmental Health|July 29, 2019
Self-reported residential pesticide use and survival after breast cancerNicole M Niehoff, Marilie D Gammon, Humberto Parada, et al.
JCO Global Oncology|December 22, 2021
Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public HospitalsYoanna Pumpalova, Alexandra M Rogers, Sarah Xinhui Tan, et al.
Cancer Investigation|January 16, 2010
Treatment interruption and discontinuation in radiotherapy for rectal cancerBenjamin Lebwohl, Leslie Ballas, Yin Cao, et al.
Cancer|June 7, 2005
Barriers to minority participation in breast carcinoma prevention trialsVictor R Grann, Judith S Jacobson, Andrea B Troxel, et al.
Pageof 60